The US Medical Tubing Market is anticipated to witness robust growth driven by technological advancements and rising healthcare requirements. The market was valued at USD 8,950 Million in 2025 and is expected to reach USD 18,240 Million by 2035, registering a CAGR of 6.8% from 2024 to 2035.
The economic impact of tariffs on "US Medical Tubing Market".
Market Growth Drivers
Rising Adoption of Minimally Invasive Procedures: The increasing preference for minimally invasive surgeries has significantly boosted demand for high-performance medical tubing. Companies such as Saint-Gobain Life Sciences have expanded their product portfolios with advanced extrusion technologies and biocompatible materials to support catheters and endoscopy. This trend is a direct response to patient preference for less traumatic medical interventions and faster recovery times, ultimately increasing the consumption of specialized tubing.
Expanding Geriatric Population and Chronic Disease Incidence: The growing population over 65 years and rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory issues have augmented the need for advanced medical devices and associated tubing. For example, Teleflex has launched a new line of tubing suited for respiratory and anesthesia markets, addressing the ongoing demand for long-term care devices and home healthcare products.
Market Trends
Focus on Biocompatible and Sustainable Materials: Key manufacturers like Zeus Industrial Products are innovating with next-generation polymer materials, such as bioabsorbable and recyclable tubes, to comply with stricter regulatory standards and sustainability goals. This trend is driven by heightened environmental concerns and the push for more eco-friendly medical device supply chains while maintaining top safety and biocompatibility standards.
Integration of Smart and Micro-Tubing Technologies: The industry is seeing rising integration of sensor-enabled and micro-scale tubing in wearable and implantable medical devices. Companies like Freudenberg Medical are pioneering micro-extrusion technology in medical tubing, enabling advancements in drug delivery systems and diagnostic devices that require precise fluid management and connectivity for remote monitoring.
Market Opportunities
Growth in Home Healthcare and Point-of-Care Devices: The shift toward decentralized healthcare, especially after the COVID-19 pandemic, is bolstering opportunities for companies providing tubing components for home-based infusion pumps and portable diagnostic kits. For instance, Nordson Medical is expanding its presence in the home care sector with tubing solutions designed for wearability and user safety.
Expansion of Customization and Rapid Prototyping Services: Manufacturers like Tekni-Plex are investing in rapid prototyping and customization capabilities, opening new opportunities to target niche medical niches with application-specific designs and quick turnaround for new device development.
US Medical Tubing Market Revenue (USD Million), 2020-2035
The chart illustrates steady upward growth in US Medical Tubing Market revenue from 2020 to 2035. Beginning at USD 6,100 Million in 2020, the market steadily climbs, with significant acceleration post-2025 as adoption of advanced and minimally invasive devices grows. By 2030, market revenue surpasses USD 13,200 Million, ultimately reaching USD 18,240 Million in 2035. This trend highlights continuous innovation, increasing healthcare demands, and the critical role of medical tubing in device development through the forecast period.
US Medical Tubing Market Share by Region (%), 2025
The 2025 market share by region pie chart demonstrates that the Northeast region dominates at 34%, attributed to concentrated healthcare infrastructure and major manufacturing bases. The Midwest follows with 22%, driven by the presence of leading medtech companies. The West region accounts for 19% with its technology-led growth, while the South holds 17% reflecting robust investment in healthcare facilities. The rest of the US, primarily less-developed markets, comprise the remaining 8%. These shares underscore the regional disparities in healthcare investment and technology adoption.
Recent Developments
In February 2024, Freudenberg Medical announced the launch of its HelixFlex™ high-purity thermoplastic elastomer tubing, designed for pharmaceutical and bioprocess applications. This innovation features enhanced biocompatibility, low extractables, and improved kink resistance, supporting advances in medical device safety and performance.
In January 2024, Saint-Gobain Life Sciences expanded its Center of Excellence for Medical Components in Massachusetts, introducing new facilities for rapid prototyping and testing of custom medical tubing. This development enhances the company's capabilities for client collaboration, product validation, and fast-tracks time to market for new device innovations.
In December 2023, Nordson MEDICAL completed the acquisition of a key extrusion technology from Optinova, strengthening its position in micro-extrusion and multi-lumen tubing. This acquisition supports Nordson's strategy to offer highly customizable and precision-engineered tubing solutions for next-generation medical and wearable devices.
Press Releases